Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-03

Clinical Trial Update: Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis [Phase 4]

View source ↗

Summary

This document reports results from a Phase 4 safety study of desirudin, an anticoagulant used for the prophylaxis of thrombosis. The study is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desirudin (desirudin)

Snippet

Sponsor: Canyon Pharmaceuticals, Inc. | Conditions: Thrombosis | Phase 4 | Status: COMPLETED | Results posted: 2013-01-03